The Queensland government has announced a further $35.5 million in funding for the $80 million Translational Manufacturing facility, citing the need to commercialise more local medical breakthroughs and strengthen sovereign manufacturing.
The support comes ahead of the state budget, to be delivered on Tuesday, June 21.
According to a statement from the Queensland government on Thursday, the new money brings the state’s contribution to three-quarters of the Translational Manufacturing facility, after previously allocating $20 million in June last year.
“That put us within striking distance of building Queensland’s first agile and multifunctional scale-up manufacturing facility capable of producing a broad range of vaccines and medical products,” said Translational Research Institute CEO Professor Scott Bell.
“With today’s announcement, this facility is now fully funded.”
Trade minister Cameron Dick said [email protected] would allow the state’s researchers and biomedical companies to more easily achieve production quantities needed to get to the clinical trial stage.
He cited the success of research by Professor Ian Frazer, co-inventor of cervical cancer Gardasil, as an example of the importance of commercialising medical breakthroughs locally.
Frazer has said elsewhere that because of Australia’s limited manufacturing of biological products, large-scale clinical trials and production were conducted overseas.
“COVID-19 taught us many lessons, but among the most important was the need for Queensland to have as much of our own sovereign manufacturing capability as possible,” said Dick.
“This is especially true when it comes to the production of vaccines and other medical treatments.”
Subscribe to our free @AuManufacturing newsletter here.